BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15057153)

  • 1. Long-term clinical outcomes of postoperative pelvic radiotherapy with or without prophylactic paraaortic irradiation for stage I-II cervical carcinoma with positive lymph nodes: retrospective analysis of predictive variables regarding survival and failure patterns.
    Kodaira T; Fuwa N; Nakanishi T; Kuzuya K; Sasaoka M; Tachibana H; Furutani K
    Am J Clin Oncol; 2004 Apr; 27(2):140-8. PubMed ID: 15057153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure.
    Stock RG; Chen AS; Flickinger JC; Kalnicki S; Seski J
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):31-6. PubMed ID: 7995765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of postoperative radiotherapy for node-negative cervical carcinoma with stage IB-IIB disease.
    Kodaira T; Fuwa N; Nakanishi T; Kuzuya K; Sasaoka M; Furutani K; Kamata M
    Jpn J Clin Oncol; 2002 Jul; 32(7):255-61. PubMed ID: 12324576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
    Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation using magnetic resonance imaging for patients with stage III cervical carcinoma treated by radiation alone in multicenter analysis: its usefulness and limitations in clinical practice.
    Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana K; Furutani K; Ogawa K
    Am J Clin Oncol; 2003 Dec; 26(6):574-83. PubMed ID: 14663375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy?
    Kodaira T; Fuwa N; Kamata M; Furutani K; Kuzuya K; Ogawa K; Toita T; Sasaoka M; Nomoto Y
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):627-36. PubMed ID: 11849783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Lee SP; Tseng CJ; Hsueh S
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1284-90. PubMed ID: 12128131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
    Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
    Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer.
    Hata M; Koike I; Miyagi E; Numazaki R; Asai-Sato M; Kasuya T; Kaizu H; Matsui T; Hirahara F; Inoue T
    Gynecol Oncol; 2013 Oct; 131(1):99-102. PubMed ID: 23877014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases.
    Cheng X; Cai SM; Li ZT; Wu XH; Ding YQ; Wang XE; Zang RY
    Int J Gynecol Cancer; 2008; 18(4):779-84. PubMed ID: 17944922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    Int J Gynecol Cancer; 2018 Oct; 28(8):1584-1591. PubMed ID: 30153215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    PLoS One; 2019; 14(4):e0214498. PubMed ID: 30986236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.